The applicability and safety of endoscopic ablation as a treatment for refractory GERD.(Anti-reflux mucosal ablation;ARMA)
Not Applicable
Recruiting
- Conditions
- PPI refractory GERD
- Registration Number
- JPRN-UMIN000032190
- Lead Sponsor
- Showa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Inability or unwillingness of patients to give written informed consent. Pregnancy. Judged unsuitable for this study by the physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The efficacy of Anti-reflux mucosal ablation for refractory GERD. f-scale and GERD-Q score 2 months, and 1 year after treatment.
- Secondary Outcome Measures
Name Time Method Adverse event rate.